Dipeptidyl Peptidase

二肽基肽酶 (Dipeptidyl Peptidase) 是广泛分布的外肽酶,在蛋白水解中起着核心作用。二肽基肽酶家族包括 DPP-IV DPP7、DPP8、DPP9、成纤维细胞活化蛋白等,它们在倒数第二个脯氨酸残基后切割肽键,并且富含药物靶标。

DPP-IV(DPP4 或 CD26)是一种丝氨酸蛋白酶,可在多种免疫细胞和各种器官的上皮细胞中检测到。除了膜结合酶外,在多种体液中还检测到具有催化活性的可溶形式。两种变体均可从各种趋化因子、神经肽和激素的 N 端切割二肽。DPP IV 通过靶向不同的底物在免疫调节、炎症、氧化应激、细胞粘附和细胞凋亡中发挥关键作用。DPP IV 抑制剂通常用作降血糖药。

DPP8 和 DPP9 表现出类似 DPPIV 的活性,并且彼此具有非常高的序列相似性。DPP8 和 DPP9 是细胞内 N 端二肽基肽酶(优先为脯氨酸后),与免疫反应和癌症生物学中的病理生理作用有关。

Dipeptidyl Peptidases are widely distributed exopeptidases that possess central role in proteolysis. The dipeptidyl peptidase family, including DPP-IV DPP7, DPP8, DPP9, fibroblast activation protein and others, cleave the peptide bond after the penultimate proline residue and are drug target rich.

DPP-IV (DPP4 or CD26) is a serine protease detected on several immune cells and on epithelial cells of various organs. Besides the membrane-bound enzyme, a catalytically active soluble form is detected in several body fluids. Both variants cleave off dipeptides from the N-termini of various chemokines, neuropeptides, and hormones. DPP IV plays a key role in immune-regulation, inflammation, oxidative stress, cell adhesion, and apoptosis by targeting different substrates. DPP IV inhibitors are commonly used as hypoglycemic agents.

DPP8 and DPP9 show DPPIV-like activity and share a very high-sequence similarity to each other. DPP8 and DPP9 are intracellular N-terminal dipeptidyl peptidases (preferentially postproline) associated with pathophysiological roles in immune response and cancer biology.

共 1种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
MK-789

MK-789 是一种脱氢肽酶 I (DHP-I) 竞争性可逆抑制剂,可通过竞争性阻断 N-甲酰亚胺基硫霉素进入近端肾小管细胞来抑制其肾脏代谢,并将 N-甲酰亚胺基硫霉素的肾脏排泄途径改为仅经肾小球滤过,从而提高其尿液回收率和肾脏清除率,因此可用于肾脏代谢与药代动力学研究。

85394-14-5
Antagonist
MK-789

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础